Zheyue Shu

471 total citations
23 papers, 337 citations indexed

About

Zheyue Shu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Zheyue Shu has authored 23 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Zheyue Shu's work include Cancer-related molecular mechanisms research (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Arrhythmias and Treatments (4 papers). Zheyue Shu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Arrhythmias and Treatments (4 papers). Zheyue Shu collaborates with scholars based in China, Australia and Madagascar. Zheyue Shu's co-authors include Kefan Bi, Hongyan Diao, Wenbiao Chen, Xujun Zhang, Dairong Xiang, Lan Gong, Jingjing Jiang, Qi Xia, Min Zhang and Xiaofeng Tang and has published in prestigious journals such as Gene, Journal of Experimental & Clinical Cancer Research and Molecular Cancer Research.

In The Last Decade

Zheyue Shu

23 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zheyue Shu China	11	154	103	61	58	49	23	337
Yingwei Zhu China	11	129 0.8×	67 0.7×	48 0.8×	73 1.3×	10 0.2×	30	302
Zhaoyang Lu China	9	179 1.2×	85 0.8×	33 0.5×	49 0.8×	24 0.5×	14	361
Haifeng Lin China	8	98 0.6×	70 0.7×	53 0.9×	108 1.9×	10 0.2×	32	303
Elina Zorde‐Khvalevsky Israel	8	156 1.0×	146 1.4×	78 1.3×	33 0.6×	8 0.2×	9	309
Siqi Ren China	10	125 0.8×	52 0.5×	27 0.4×	91 1.6×	49 1.0×	34	318
Yulan Liu China	11	110 0.7×	52 0.5×	71 1.2×	36 0.6×	35 0.7×	28	356
Dayan Cao China	11	120 0.8×	29 0.3×	74 1.2×	47 0.8×	36 0.7×	18	319
Robert W. Hu United States	8	131 0.9×	46 0.4×	33 0.5×	54 0.9×	43 0.9×	16	265
Zuojian Hu China	9	100 0.6×	83 0.8×	47 0.8×	98 1.7×	9 0.2×	34	274

Countries citing papers authored by Zheyue Shu

Since Specialization

Citations

This map shows the geographic impact of Zheyue Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheyue Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheyue Shu more than expected).

Fields of papers citing papers by Zheyue Shu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheyue Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheyue Shu. The network helps show where Zheyue Shu may publish in the future.

Co-authorship network of co-authors of Zheyue Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Zheyue Shu. A scholar is included among the top collaborators of Zheyue Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheyue Shu. Zheyue Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yi, et al.. (2024). Prediction of Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome. Japanese Journal of Infectious Diseases. 78(1). 28–34. 2 indexed citations

Shu, Zheyue, Xueyao Wang, Liang Hong, et al.. (2024). Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape. Molecular Cancer Research. 22(7). 642–655. 10 indexed citations

Jiang, Shiman, Yanfei Chen, Zheyue Shu, et al.. (2024). Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease. Science China Life Sciences. 67(6). 1183–1198. 13 indexed citations

Ye, Ting, et al.. (2023). Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection. Digestive Diseases. 42(1). 53–60. 2 indexed citations

Wang, Qiqi, Qi Xia, Dongchen Zhou, et al.. (2022). Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation. Cardiovascular Drugs and Therapy. 37(3). 549–560. 15 indexed citations

Wang, Qiqi, et al.. (2022). Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China. Frontiers in Public Health. 9. 758874–758874. 17 indexed citations

Shu, Zheyue, Feng Gao, Qi Xia, & Min Zhang. (2021). Mir-9-5P Promotes Cell Proliferation and Migration of Hepatocellular Carcinoma By Targeting Cpeb3. Biomarkers in Medicine. 15(2). 97–108. 18 indexed citations

Shu, Zheyue, Miao Chen, Qiqi Wang, et al.. (2021). High-Normal Thyroid Function and Recurrence of Atrial Fibrillation after Catheter Ablation: A Prospective Observational Study. Cardiology. 146(5). 607–615. 3 indexed citations

Li, Li, Jiawei Zhou, Shuai Wang, et al.. (2021). Critical role of peroxisome proliferator-activated receptor α in promoting platelet hyperreactivity and thrombosis under hyperlipidemia. Haematologica. 107(6). 1358–1373. 22 indexed citations

10.

Chen, Wenbiao, Jingjing Jiang, Lan Gong, et al.. (2021). Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis. Journal of Experimental & Clinical Cancer Research. 40(1). 1–1. 123 indexed citations

11.

Guo, Dazhi, et al.. (2021). [Establishment of human colon cancer transplantation tumor model in normal immune mice].. PubMed. 43(9). 939–943. 1 indexed citations

12.

Tang, Xiaofeng, Zheyue Shu, & Shusen Zheng. (2020). The complexity of immune cell landscape in hepatocellular carcinomas with different risks—reply letter. Annals of Translational Medicine. 8(11). 729–729. 1 indexed citations

13.

Xia, Qi, Zheyue Shu, Ting Ye, & Min Zhang. (2020). Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma. Frontiers in Genetics. 11. 595699–595699. 5 indexed citations

14.

Wang, Qiqi, Miao Chen, Jianqiang Zhao, et al.. (2020). Investigation of proper home blood pressure with atrial fibrillation recurrence in patients undergoing radiofrequency catheter ablation. PubMed. 68(3). 224–233. 1 indexed citations

15.

Liu, Li, Danyang Wang, Yun Ding, et al.. (2020). The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis. Gene. 769. 145187–145187. 7 indexed citations

16.

Shu, Zheyue, et al.. (2020). Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells. Hepatobiliary & pancreatic diseases international. 19(6). 547–554. 6 indexed citations

17.

Tang, Xiaofeng, Zheyue Shu, Weichen Zhang, et al.. (2019). Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis. Annals of Translational Medicine. 7(20). 528–528. 25 indexed citations

18.

Wang, Qiqi, Yunpeng Shang, Jianqiang Zhao, et al.. (2019). U-Shaped Relationship Between Left Atrium Size on Echocardiography and 1-Year Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation　― Prognostic Value Study ―. Circulation Journal. 83(7). 1463–1471. 9 indexed citations

19.

Tang, Xiaofeng, Zheyue Shu, Xiaodong Shen, et al.. (2018). MicroRNA‑223 promotes hepatocellular carcinoma cell resistance to sorafenib by targeting FBW7. Oncology Reports. 41(2). 1231–1237. 14 indexed citations

20.

Shi, Yu, et al.. (2010). Interferon and lamivudine combination therapy versus lamivudine monotherapy for hepatitis B e antigen-negative hepatitis B treatment: a meta-analysis of randomized controlled trials.. PubMed. 9(5). 462–72. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact